Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depends on the ...

Objective: To review the basis for the estimated comparative daily dosages of inhaled corticosteroids for children and adults that are presented in the National Heart, Lung, and Blood Institute's ...

The global Cystic Fibrosis Market is valued at $10.4 billion in 2023 and is projected to reach $55.4 billion by 2032, ...

The Commerce Committee held a hearing for a new bill that would ban the sale of flavored nitrous oxide cannisters, also known ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Alabama lawmakers are considering a bill to restrict sales and use of nitrous oxide, or laughing gas, a product linked to at least five deaths in Shelby County last year. The gas canisters are ...

Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive ... becoming the first inhaled product with a novel mechanism of action available for the maintenance ...

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)1 and OXB,1 today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, gene ...